Aprinoia Therapeutics (Aprinoia Therapeutics) Effective Interest Rate on Debt % : 31.56% (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Aprinoia Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Jun. 2023 was $2.89 Mil. Aprinoia Therapeutics's average total debt for the quarter that ended in Jun. 2023 was $9.15 Mil. Therefore, Aprinoia Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 was 31.56%.

Aprinoia Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Aprinoia Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Effective Interest Rate on Debt % Chart

Aprinoia Therapeutics Annual Data

Trend

Dec21

Dec22

Effective Interest Rate on Debt %

3.23

3.50

Aprinoia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23
Effective Interest Rate on Debt %	-	2.33	3.99	31.56

Competitive Comparison of Aprinoia Therapeutics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Aprinoia Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprinoia Therapeutics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Effective Interest Rate on Debt % falls into.

Aprinoia Therapeutics Effective Interest Rate on Debt % Calculation

Aprinoia Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2022 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2021 )	+	Total Debt (A: Dec. 2022 ))	/ count )
=	-1 * -0.067	/	( (1.116	+	2.709)	/ 2 )
=	-1 * -0.067	/	1.9125
=	3.50 %

where

	Total Debt (A: Dec. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.177	+	0.939
=	1.116

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.042	+	2.667
=	2.709

Aprinoia Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2022 )	+	Total Debt (Q: Jun. 2023 ))	/ count )
=	-1 * -2.888	/	( (2.709	+	15.595)	/ 2 )
=	-1 * -2.888	/	9.152
=	31.56 %

where

	Total Debt (Q: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.042	+	2.667
=	2.709

	Total Debt (Q: Jun. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.015	+	15.58
=	15.595

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Jun. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Aprinoia Therapeutics (NAS:APRI) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Aprinoia Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines